Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
시장
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Tape desk, TradeNews BD (2026-10-13): Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim. 1차 출처: CNBC Top News 원문 (cnbc.com).